A detailed history of Bell Investment Advisors, Inc transactions in Glaukos Corp stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 23 shares of GKOS stock, worth $3,589. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Previous 23 -0.0%
Holding current value
$3,589
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$89.48 - $118.35 $536 - $710
6 Added 35.29%
23 $2,000
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $357 - $510
6 Added 54.55%
17 $1,000
Q4 2021

Feb 14, 2022

BUY
$40.27 - $56.99 $40 - $56
1 Added 10.0%
11 $0
Q3 2021

Nov 12, 2021

BUY
$47.43 - $84.23 $474 - $842
10 New
10 $0

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.43B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.